Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Vermeulen

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
NPJ Systems Biology and Applications|December 13, 2025
Challenges and opportunities for oncology drug repurposing informed by synthetic lethalityMichael Vermeulen, Andrew W Craig, Tomas Babak
Iscience|March 5, 2021
<i>Cis-</i>regulatory mutations with driver hallmarks in major cancersZhongshan Cheng, Michael Vermeulen, Micheal Rollins-Green, et al.
STAR Protocols|November 24, 2021
Identifying tumorigenic non-coding mutations through altered <i>cis</i>-regulationZhongshan Cheng, Michael Vermeulen, Micheal Rollins-Green, et al.
Journal of Visualized Experiments : Jove|November 27, 2023
Gut Isolation from Zebrafish Larvae for Single-cell RNA SequencingNaomi J M Kakiailatu, Laura E Kuil, Eric Bindels, et al.
Brain Research|July 27, 2019
Somatic mosaicism of sex chromosomes in the blood and brainEmma J Graham, Michael Vermeulen, Badri Vardarajan, et al.
Neurogastroenterology and Motility|September 12, 2025
Retinoic Acid Inhibition Alters Intestinal Composition in Zebrafish: A Non-genetic Model to Study Hirschsprung Disease?Naomi J M Kakiailatu, Wei Zhang, Laura E Kuil, et al.
Nature Communications|September 29, 2021
The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loopsSophie Ottema, Roger Mulet-Lazaro, Claudia Erpelinck-Verschueren, et al.
Brain : a Journal of Neurology|December 12, 2022
AAV5-miHTT-mediated huntingtin lowering improves brain health in a Huntington's disease mouse modelSarah B Thomson, Anouk Stam, Cynthia Brouwers, et al.
Hemasphere|January 12, 2026
Daratumumab-based quadruplet for patients with extramedullary multiple myeloma: Results from the Phase II prospective EMN19 studyMeral Beksac, Tulin Fıratlı Tuglular, Francesca Gay, et al.
Blood Advances|December 22, 2020
Prognostic and predictive performance of R-ISS with SKY92 in older patients with multiple myeloma: the HOVON-87/NMSG-18 trialRowan Kuiper, Sonja Zweegman, Mark van Duin, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
NPJ Systems Biology and Applications|December 13, 2025
Challenges and opportunities for oncology drug repurposing informed by synthetic lethalityMichael Vermeulen, Andrew W Craig, Tomas Babak
Iscience|March 5, 2021
<i>Cis-</i>regulatory mutations with driver hallmarks in major cancersZhongshan Cheng, Michael Vermeulen, Micheal Rollins-Green, et al.
STAR Protocols|November 24, 2021
Identifying tumorigenic non-coding mutations through altered <i>cis</i>-regulationZhongshan Cheng, Michael Vermeulen, Micheal Rollins-Green, et al.
Journal of Visualized Experiments : Jove|November 27, 2023
Gut Isolation from Zebrafish Larvae for Single-cell RNA SequencingNaomi J M Kakiailatu, Laura E Kuil, Eric Bindels, et al.
Brain Research|July 27, 2019
Somatic mosaicism of sex chromosomes in the blood and brainEmma J Graham, Michael Vermeulen, Badri Vardarajan, et al.
Neurogastroenterology and Motility|September 12, 2025
Retinoic Acid Inhibition Alters Intestinal Composition in Zebrafish: A Non-genetic Model to Study Hirschsprung Disease?Naomi J M Kakiailatu, Wei Zhang, Laura E Kuil, et al.
Nature Communications|September 29, 2021
The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loopsSophie Ottema, Roger Mulet-Lazaro, Claudia Erpelinck-Verschueren, et al.
Brain : a Journal of Neurology|December 12, 2022
AAV5-miHTT-mediated huntingtin lowering improves brain health in a Huntington's disease mouse modelSarah B Thomson, Anouk Stam, Cynthia Brouwers, et al.
Hemasphere|January 12, 2026
Daratumumab-based quadruplet for patients with extramedullary multiple myeloma: Results from the Phase II prospective EMN19 studyMeral Beksac, Tulin Fıratlı Tuglular, Francesca Gay, et al.
Blood Advances|December 22, 2020
Prognostic and predictive performance of R-ISS with SKY92 in older patients with multiple myeloma: the HOVON-87/NMSG-18 trialRowan Kuiper, Sonja Zweegman, Mark van Duin, et al.
Pageof 2